Thursday, 13 November 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 13 November 2025
News

Lack of choice fuels med poisoning

Posted 12 November 2025 PM

A lack of dosage options may be contributing to a surge in poisonings from medications used to treat ADHD, with the rate of poisonings quadrupling over a decade and more than two-thirds of cases coming from just two drugs.

Researchers from Sydney University published Exposures to attention deficit hyperactivity disorder medications reported to the New South Wales Poisons Information Centre in the Australian & New Zealand Journal of Psychiatry, using nationwide data from the NSW Poisons Information Centre to detect a rise in poisonings from ADHD medications from 795 in 2014 to 3,242 in 2023.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (15)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Other (14)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.